Cargando…
TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men
Male hypogonadism is characterized by symptoms and deficiency (<300 ng/dL) in levels of in total testosterone (TT), a critical hormone for sexual, cognitive, and body function and development. TLANDO, a testosterone undecanoate (TU) comprising lymphatically delivered oral testosterone replacement...
Autores principales: | Bruno, Benjamin J, Vangara, Kiran, Kim, Kilyoung, Papangkorn, Kongnara, Chidambaram, Nachiappan, Patel, Mahesh V, DelConte, Anthony, Carson III, Culley C, Goldstein, Irwin, Kaminetsky, Jed, Miner, Martin, Khera, Mohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090604/ http://dx.doi.org/10.1210/jendso/bvab048.1012 |
Ejemplares similares
-
Efficacy and Safety of TLANDO, A Novel Oral Easy to Prescribe and Use TRT Option
por: Papangkorn, Kongnara, et al.
Publicado: (2021) -
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022) -
SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020) -
SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020) -
Low Testosterone in Males May Warrant Liver Health Assessment and Intervention
por: DelConte, Anthony, et al.
Publicado: (2021)